Background: Recently, a second prostaglandin D 2 (PGD 2 ) receptor, chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2), was identified. Because PGD 2 was reported to have chemotactic activity on eosinophils, CRTH2 expressed on eosinophils attracted interest as a receptor associated with eosinophil migration to, and accumulation at, inflammatory sites. To elucidate the mechanism regulating the expression of CRTH2 on eosinophils, the effects of PGD 2 , interleukin (IL)-4, IL-5 and interferon (IFN)-γ on CRTH2 expression were investigated. Methods: Blood eosinophils were purified using Percoll and anti-CD16 antibody coated magnetic beads. Eosinophils were incubated with PGD 2 and/or IL-4, IL-5 and IFN-γ . The expression of CRTH2 on eosinophils was measured using a FACScan cytometer (Becton Dickinson Immunocytometry Systems, San Jose, CA, USA). Results: Prostaglandin D 2 and IL-5, but not IL-4 and IFN-γ , downregulated the expression of CRTH2 on eosinophils. Furthermore, PGD 2 -and IL-5-induced downregulation of CRTH2 on human eosinophils was inhibited by phenylarsine oxide, a receptor internalization inhibitor. Conclusions: These results suggest that PGD 2 and IL-5 regulate CRTH2 expression on eosinophils through
I NTRODUCTION
Allergic inflammation is characterized by the selective accumulation of inflammatory cells, such as activated Th2 lymphocytes and eosinophils. The Th2 cells, as well as eosinophils, play an essential role in the pathogenesis of allergic inflammation.
1,2 Phenotypic characterization of Th2 cells has become a focus of interest. Chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) was recently cloned as a Th2-selective surface molecule distinguished from Th1 cells. 3 It was also found that CRTH2 was expressed on eosinophils in addition to Th2 cells. 4 Interestingly, CRTH2 was recently identified as a second receptor for prostaglandin D 2 (PGD 2 ).
5 Prostaglandin D 2 is a major arachidonic acid metabolite released by antigen-activated mast cells 6 and Th2 cells. Large amounts of PGD 2 are generated in the asthmatic lung. 8, 9 Prostaglandin D 2 and CRTH2 may be implicated in the pathogenesis of allergic diseases.
The mechanism by which CRTH2 expression is regulated is unclear. Therefore, in the present study, the modulation of surface CRTH2 expression on human eosinophils by PGD 2 , Th2 cytokines (such as interleukin (IL)-4 and IL-5)and Th1 cytokines (such as interferon (IFN)-γ ), was investigated. 
M ETHODS Eosinophil purification
Peripheral venous blood was obtained from subjects with mild to moderate eosinophilia. Eosinophil donors were either healthy or had mild allergic rhinitis and blood was obtained at a time when they were relatively asymptomatic and off medication. Eosinophils were isolated by sedimentation with 6% dextran followed by centrifugation on 1.088 Percoll (Pharmacia, Uppsala, Sweden) density gradients, as modified from the method of Hansel et al . 10, 11 Cells were further purified by negative selection using anti-CD16 immunomagnetic beads and a MACS system (Miltenyi Biotec, Bergisch Gladbach, Germany). Eosinophils were then suspended in Hank's balanced salt solution (HBSS; Life Technologies, Grand Island, NY, USA) with 1% fetal calf serum (FCS) in tubes coated with 3% human serum albumin. The resulting eosinophil purity was more than 99%.
Flow cytometric analysis of surface CRTH2
This method was used for studying the effect of PGD 2 on CRTH2 surface expression. Eosinophils were resuspended at 1 × 10 6 cells/mL in RPMI 1640 (Gibco, Grand Island, NY, USA) supplemented with 10% FCS and incubated with various concentrations of PGD 2 and IL-4 (5 ng/mL) or IL-5 (5 ng/mL) or IFN-γ (100 U/mL) for 3 h at 37 ° C. Cells were washed twice with phosphatebuffered saline (PBS) and then stained with biotinylated antihuman CRTH2 antibody (Ab; BM-16; final concentration 10 µ g/mL; a kind gift from Dr Kinya Nagata and Dr Hiroyuki Hirai, Bio Medical Laboratories, Saitama, Japan) and phycoerythrin (PE)-labeled streptavidin. BM16 is not a neutralizing anti-CRTH2 monoclonal antibody (mAb). Biotinylated rat IgG2a Ab (Becton Dickinson, San Jose, CA, USA) was used as an isotype-matched control. Stained cells were analyzed using a flow cytometer (FACScan; Becton Dickinson Immunocytometry Systems, San Jose, CA, USA). The expression of CRTH2 is given as change in mean fluorescence intensity ( ∆ MFI), that is, the difference in MFI between the sample and the isotype-matched control.
Blockade of CRTH2 internalization on eosinophils
Inhibition of internalization of surface CRTH2 was assayed by eosinophils pretreated with 8 µ mol/L phenylarsine oxide (PAO; Sigma-Aldrich, St Louis, MO, USA) for 5 min and then treated with PGD 2 (100 nmol/L) or IL-5 (5 ng/mL) for 3 h at 37 ° C. The PAO (8 µ mol/L) was non-toxic to cells (as assessed by annexin V-fluorescein isothiocyanate and propidium iodide (PI) staining).
Flow cytometric analysis of intracellular or whole (intracellular and surface) CRTH2 expression
The method used is a modification of a method described earlier.
12 Briefly, eosinophils were resuspended at 1 × 10 6 cells/mL in RPMI 1640 supplemented with 10% FCS and incubated with PGD 2 (100 nmol/L) for 3 h at 37 ° C. After being washed in PBS, cells were stained with non-biotinylated BM16 (for intracellular staining) or biotinylated BM16 (for whole staining) at a final concentration of 10 µ g/mL in PBS for 30 min at 4 ° C. Then, 2 mL lysing solution (FACS TM Lysing Solution; Becton Dickinson) was added to each sample for 10 min in the dark at room temperature. After washing, permeabilizing solution (FACS TM Permeabilizing Solution; Becton Dickinson) was added for 10 min in the dark at room temperature. After being washed in PBS, cells were incubated for 30 min with BM16 or isotype-matched Ab (rat IgG2a) at a final concentration of 30 µ g/mL in PBS for 30 min at 4 ° C. Cells were washed with PBS and then stained with PE-labeled streptavidin for 30 min at 4 ° C. Stained cells were analyzed using a flow cytometer.
Statistical analysis
Data are presented as the mean ± SD. A one-way ANOVA with repeated measures was used for comparison of more than two variables. When the initial P -value was less than 0.05, Scheffé's F -test was used to determine the significance between groups. Significance was established at P < 0.05.
R ESULTS
Effect of PGD 2 , IL-4, IL -5 and IFN-γ on CRTH2 surface expression
We conducted in vitro studies aimed at elucidating the mechanism controlling the expression of CRTH2 on eosinophils. We selected PGD 2 , IL-4, IL-5 and IFN-γ as possible factors that control CRTH2 expression on eosinophils at allergic inflammatory sites. Prostaglandin D 2 reduced CRTH2 surface expression on human eosinophils in a dose-dependent manner. The surface expression of CRTH2 decreased significantly to 74.7 ± 5.3, 47.5 ± 10.2 and 43.8 ± 11.4% (compared with medium alone) following stimulation with PGD 2 at concentrations of 10, 100 and 1000 nmol/L, respectively (Fig. 1a) . Neither IL-4 nor IFN-γ was able to significantly modulate the surface expression of CRTH2. The surface expression of CRTH2 decreased significantly to 80.1 ± 10.8% (compared with medium alone) following stimulation with IL-5 (5 ng/mL; Fig. 1b) . The dose of IL-5 used in the present study was chosen on the basis of results from previous studies showing that IL-5 specifically bound to eosinophils and reached saturation at an approximate concentration of 1-1.25 nmol/L. 13, 14 Eosinophils were incubated with PGD 2 (100 nmol/L) and IL-4 (5 ng/mL) or IL-5 (5 ng/mL) or IFN-γ (100 U/mL) for 3 h. The reduction in the surface expression of CRTH2 was not enhanced by the addition of cytokines compared with eosinophils incubated with PGD 2 alone (Fig. 1c) .
Effect of PAO pretreatment on PGD 2 -and IL-5-induced CRTH2 downregulation on eosinophils
To elucidate the mechanism of CRTH2 downregulation on eosinophils, we pretreated eosinophils with PAO, an inhibitor of receptor internalization, 15 following PGD 2 or IL-5 treatment. In the present study, PAO inhibited PGD 2 -and IL-5-induced CRTH2 downregulation on human eosinophils ( Fig. 2a ; Table 1 ).
Effect of PGD 2 on whole and intracellular CRTH2 expression in human eosinophils
Whole CRTH2 expression in PGD 2 -treated eosinophils (43.1 ± 15.3 ∆ MFI) was significantly lower than that in non-treated eosinophils (74.5 ± 14.3 ∆ MFI). In contrast, there was no difference in the intracellular expression of CRTH2 before (20.1 ± 1.14 ∆ MFI) and after (20.8 ± 4.96 ∆MFI) treatment with PGD 2 (Fig. 2b) .
DISCUSSION
Prostaglandin D 2 , a ligand against CRTH2 expressed on Th2 cells and eosinophils, is produced in the asthmatic lung and is considered to be an important proinflammatory mediator in allergic disease. 16 Because PGD 2 was reported to have chemotactic activity on eosinophils, 5, 17 CRTH2 expressed on eosinophils attracted interest as a receptor associated with eosinophil migration to, and accumulation at, inflammatory sites. CRTH2 is one of seven transmembrane G-protein-coupled receptors as well as a chemokine receptor. 5 One proposed regulatory mechanism for the expression of the seven transmembrane G-protein-coupled chemokine receptors, such as CCR1, CCR2b, CCR3 and CXCR4, is ligand-induced internalization. [18] [19] [20] [21] Cytokines have also been shown to modulate surface protein expression and mRNA expression for certain chemokine receptors. For example, IL-3, IL-5, granulocyte-macrophage colony stimulating factor (GM-CSF) and IL-4 attenuated the surface expression of CXCR4. 21 In contrast, the regulatory mechanism for the expression of CRTH2 is not well understood. We have observed, in a case of eosinophilic pneumonia, that the expression of CRTH2 on bronchoalveolar lavage fluid (BALF) eosinophils was much lower than that of eosinophils in peripheral blood (∆MFI: 27.5 vs 132.3, respectively; K Hamada et al., unpubl. obs.). This observation suggested the presence of unknown factors produced at the inflammatory site regulating the expression of CRTH2 on eosinophils. Moreover, the expression of CCR3 on eosinophils in BALF was also lower than that on peripheral eosinophils. Indeed, in the present study, we chose PGD 2 , IL-4, IL-5 and IFN-γ as possible factors and found that PGD 2 and IL-5 downregulated the expression of CRTH2 on eosinophils. Hirai et al. reported the downregulatory effect of PGD 2 on the expression of CRTH2 on Th2 cells. 22 As has been reported for chemokine receptors, such as CCR1, CCR3 and CXCR4, although it is only one of several possible explanations, ligand-induced Data are the mean ± SD. Scheffé's F-test was used to determine the significance between groups (n = 3).
FACS analysis was performed to assess surface expression of CRTH2 on eosinophils. internalization is the regulatory mechanism responsible for the downregulation of CRTH2. Indeed, the internalization inhibitor PAO inhibited PGD 2 -and IL-5-induced CRTH2 downregulation on human eosinophils. Thus, the mechanism of CRTH2 downregulation may be receptor internalization. Interestingly, the intracellular expression of CRTH2, which was expected to increase as a result of internalization, was not changed by PGD 2 . Unchanged intracellular expression of CRTH2 after PGD 2 stimulation suggested the degradation of CRTH2 following CRTH2 internalization. Ligandinduced downregulation of receptor expression may explain the diminished chemotactic migration after repetitive stimulation by a certain chemoattractant.
23
The decreased expression of CRTH2 on tissue eosinophils may make these cells remain at the site of allergic inflammation.
In summary, PGD 2 and IL-5 reduced CRTH2 expression on human eosinophils. Further studies are necessary to elucidate the mechanism and clinical relevance of PGD 2 -and IL-5-induced CRTH2 downregulation.
